Remote Speech Analysis in HF Patients Undergoing Haemodialysis

• Patients undergoing hemodialysis every 5-10 days in order to balance their volume overload.
• Class C Heart Failure patient with reduced EF CHF (EF\<40%) and NYHA 2-3.
• Patients with dyspnea clinically related to pulmonary congestion
• Patient with more than 3 months HF disease duration.
• The patient is willing to participate as evidenced by signing the written informed consent.
• Male or non-pregnant female patient

Exclusion Criteria:

• Subject who, in the Investigator's opinion, unable to comply with the daily use of the App due to mental disorders (e.g., depression, dementia).
• Patient who has had a major cardiovascular event (e.g., myocardial infraction, stroke) within 3 months prior to screening visit.
• Patients likely to undergo heart transplantation/ LVAD within 6 months of Screening Visit or baseline functional capacity of NYHA 4.
• Patients with evidence of active Infection.
• Patient with severe alcohol or drug use.
• Psychological instability, inappropriate attitude or motivation.
• Patient with life threatening debilitating disease other than cardiac.
• Subject currently enrolled in another investigational device or drug trial that has not completed the primary endpoint or that clinically interferes with the current study endpoints.